Skip to main content

Dr. Gregory R. Thoreson, M.D.

Urology (Urology Physician)

  • Medicare participating

At a glance

Years since graduation
16
In the NPI registry since
2010
Medicare patients seen, 2024
664

Licensed in Texas since 2015, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2010Medical school: University of Texas Medical School at San Antonio
  • 2010Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Urology Physician primary
    TX license Q4316 (first issued 2015; active)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Urology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
664
Services billed
5,370
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes705388
Automated urinalysis test526348
Manual urinalysis test with examination using microscope, automated308212
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month25438
Detection test by nucleic acid for organism, amplified probe technique23417
Insertion of needle into vein for collection of blood sample205131
Ultrasound measurement of bladder capacity after voiding179134
Psa (prostate specific antigen) measurement, total14997
New patient office or other outpatient visit, 45-59 minutes140140
Bacterial urine culture11956

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 22 companies reported 72 payments worth $8,043 in total to this clinician.

By type
Consulting Fee$4,180
Food and Beverage$2,028
Travel and Lodging$1,834

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Apr 9, 2025Pfizer Inc.
Apr 9, 2025
Consulting Fee$2,000
Apr 27, 2025Janssen Scientific Affairs, LLC
Apr 27, 2025
Consulting Fee$1,363
Apr 27, 2025Janssen Biotech, Inc.
Apr 27, 2025
Consulting Fee$818
Oct 14, 2025Intuitive Surgical, Inc.
Oct 14, 2025
Travel and Lodging
Da Vinci Surgical System · SURGERY · travel to CLEVELAND, OH · in-kind
$817
May 7, 2025Pfizer Inc.
May 7, 2025
Travel and Lodging
travel to CHICAGO, IL
$701
Nov 13, 2025Intuitive Surgical, Inc.
Nov 13, 2025
Travel and Lodging
Da Vinci Surgical System · SURGERY · travel to CLEVELAND, OH · in-kind
$298
Oct 14, 2025Intuitive Surgical, Inc.
Oct 14, 2025
Travel and Lodging
Da Vinci Surgical System · SURGERY · travel to CLEVELAND, OH · in-kind
$19.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,250 in research payments for these studies, mostly to the institutions running them.

  • A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizumab versus Cystectomy Alone in Participants who are Cisplatin-Inelig…
    Merck Sharp & Dohme LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Urology clinicians in Dallas

Sources

NPI registry (CMS NPPES, November 2026; record last updated January 19, 2017), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1093034126. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.